Home

R JOHN FLETCHER

CIK 1215024 · last filed 2026-07-06

R JOHN FLETCHER is a corporate insider who has filed 149 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider was granted $11.8K of CLPT on Jul 6, 2026. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.88M

Companies

8

Total Filings

149

Lifetime Open-Market Net

-$3.05M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CLPT Director 131,011 $14.57 $1.91M $0 37 2026-07-06
KRMD Director 232,157 $3.40 $789.3K $207.6K 31 2026-07-01
OptiNose, Inc. (OPTN) Delisted Director — $9.60 — $0 4 2025-05-21
Vyant Bio, Inc. (VYNT) Delisted Director 29,955 $0.19 $5.8K $101.8K 9 2023-01-19
ACLS Director 1,354 $132.65 $179.6K -$2.96M 23 2021-02-17
SPECTRANETICS CORP (SPNC) Delisted Director 141,697 — — -$403.2K 17 2017-06-12
Adhera Therapeutics, Inc. (MRNAD) Delisted Director — — — $0 1 2011-09-07
PANACOS PHARMACEUTICALS, INC. (PANC) Delisted Director — — — $0 3 2008-06-30

Recent Filings

149 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-06 CLPT Grant (A) +662 $11.8K EDGAR
2026-07-01 KRMD Grant (A) +5,357 $22.5K EDGAR
2026-05-26 CLPT Grant (A) — $0 EDGAR
2026-05-21 CLPT Exer (M) +12,417 $0 EDGAR
2026-04-02 CLPT Grant (A) +1,270 $11.6K EDGAR
2026-04-01 KRMD Grant (A) +5,208 $22.5K EDGAR
2026-01-05 CLPT Grant (A) +422 $5.8K EDGAR
2026-01-02 KRMD Grant (A) +3,872 $22.5K EDGAR
2025-10-02 KRMD Grant (A) +5,874 $22.5K EDGAR
2025-10-02 CLPT Grant (A) +265 $5.8K EDGAR
Showing 1–10 of 149
Page 1 of 15
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.